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Abstract 
Macroamylasemia is a biochemical disorder characterized by an elevated serum amylase 
activity resulting from the circulation of a macromolecular complex of amylase with a 
serum component, often an immunoglobulin. The increased molecular weight of this 
complex prevents the normal renal excretion of the enzyme. A few cases of celiac 
patients with macroamylasemia have been published in whom the biochemical disorder 
disappeared after treatment with a gluten-free diet. 
 
Background 
Macroamylasemia occurs in approximately 0.4% of the general population, and about 
2.5–5.9% of these patients have hyperamylasemia. Hyperamylasemia may be either an 
isolated, benign laboratory finding without pathological significance or it may be 
associated with underlying diseases, such as lymphoma, AIDS, carcinoma, liver disease 
and autoimmune disorders. The circulating macroamylase complexes of pancreatic or 
salivary amylase are bound to plasma proteins which cannot be cleared by the renal
 
glomeruli. In most cases, the macromolecular amylase represents a complex of normal 
amylase and either immunoglobulin A or G and
 may be a specific antigen-antibody 
complex [1, 2]. Celiac disease is a permanent intolerance to ingested gluten that results in
 
immunologically mediated inflammatory damage of the small intestinal mucosa. Several 
recent population-based serologic surveys have
 shown celiac disease to be a common 
disorder, possibly affecting 1 in 200–250 individuals in most countries studied. Only few 
cases of celiac disease associated with macroamylasemia have
 been described, and the 
macroamylasemia disappeared once the patients followed a gluten-free diet [3–9]. We 
describe a patient in whom celiac disease was the cause of persistent hyperamylasemia.  
Case Rep Gastroenterol 2008;2:196–198 
DOI: 10.1159/000132771 
Published online: June 6, 2008  © 2008 S. Karger AG, Basel 
ISSN 1662–0631 
www.karger.com/crg 
 
 
197
Case Report 
A 52-year-old woman was referred to our outpatient clinic with a 6-month history of weakness, 
weight loss of 6 kg, maculopapular rash on her legs and persistent hyperamylasemia for 3 months 
(amylase >1,400 U [normal 35–120 U] and very low 24-hour urine amylase and amylase 
clearance/creatinine clearance ratio (1.9% [normal 3.0 ± 1.1%]), consistent with macroamylasemia. Her 
medical history was remarkable only for several years of chronic normocytic normochromic anemia 
(Hb 9.9 g%) and osteoporosis. She was not receiving any medications. Other than a sallow pallor and 
the maculopapular rash on both legs, the physical examination was completely negative. Laboratory 
results: thrombocytosis (510,000 platelets/ml), albumin 3.1 g, AST 60 U (normal 15–30), rheumatoid 
factor 81 (normal 0–15), anti-mitochondrial antibody (AMA) 1:80. The rest of the laboratory results 
were normal. An abdominal computerized tomogram with contrast yielded no pathological findings. 
Biopsy from the skin lesions on her legs revealed leukocytoclastic vasculitis. 
Our patient had macroamylasemia and anemia, which can present as an autoimmune disease, such 
as celiac disease. Her serology for celiac disease was strongly positive, and she underwent 
esophagogastroduodenoscopy which revealed scalloping of folds in the second part of the duodenum. A 
histological evaluation confirmed the diagnosis of celiac disease. The patient was started on a gluten-free 
diet which led to a significant clinical improvement two months later: she felt generally stronger, had 
gained weight, the rash had disappeared, the serum amylase values were normal, hemoglobin had 
increased to 11.7 g%, and there was a return of serum albumin to normal values. 
Conclusion 
The case we describe demonstrates an association between celiac disease and other 
medical conditions that present as macroamylasemia. Celiac disease was the cause and 
first manifestation of her persistent hyperamylasemia. We recommend ruling out celiac 
disease in cases of unexplained hyperamylasemia. 
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